Related Experiment Video
Updated: Jan 21, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hypertrophic cardiomyopathy: New hope for an old disease
Gail Larkin1, Tamara Bellomo, Lenel Caze
1Gail Larkin and Lenel Caze are assistant professors in the Paramedic Program within the Nursing Department at Kingsborough Community College in Brooklyn, NY. Tamara Bellomo is an associate professor in the Nursing Program in the Nursing Department, also at Kingsborough Community College.
Insights
Hypertrophic cardiomyopathy (HCM) is a common congenital heart disease leading to sudden cardiac death in young people. While older adults with HCM face fewer sudden deaths, their quality of life may suffer, necessitating specific care strategies.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is a prevalent genetic heart condition.
- It is the primary cause of sudden cardiac death in young individuals, including athletes.
- While less common in older adults, HCM significantly impacts their quality of life.
Purpose of the Study:
- To outline current diagnostic criteria for hypertrophic cardiomyopathy in adults.
- To review established and emerging treatment options for HCM.
- To detail essential nursing interventions and patient education strategies for adults with HCM.
Main Methods:
- Review of current medical literature and clinical guidelines.
- Analysis of diagnostic approaches for HCM.
- Synthesis of treatment modalities and nursing care principles.
Main Results:
- Diagnostic criteria for HCM involve clinical, imaging, and genetic assessments.
- Treatment strategies range from medication to surgical interventions and device therapy.
- Nursing care focuses on symptom management, medication adherence, and lifestyle modifications.
Conclusions:
- Early diagnosis and comprehensive management are crucial for improving outcomes in adults with HCM.
- Tailored nursing interventions, including patient education, enhance quality of life and reduce complications.
- Ongoing research aims to refine treatment protocols and personalize care for HCM patients.
Abstract:
Hypertrophic cardiomyopathy (HCM), a common congenital heart disease, is the leading cause of sudden cardiac death in adolescents, young adults, and athletes. Older adults with HCM are less likely to experience sudden cardiac death, but their quality of life can be impaired. This article discusses diagnostic criteria, treatments, and nursing interventions, including patient teaching, for adults with HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management
Cardiomyopathy V: Interprofessional Care

